tbuckley/cabot-search huggingface dataset:
Undertriage of Firearm-Related Injuries or Insufficient Granularity of Data?
Authors: Marie Crandall
Journal: JAMA Surgery (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Surgery HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Surgery journal
Impairment of Longitudinal Growth By Tyrosine Kinase Inhibitor (TKI) Treatment - Data from a Large Pediatric Cohort with Chronic Myeloid Leukemia (CML)
Authors: Josephine Tabea Tauer, Christina Nowasz, Petr Sedlacek, Eveline S.J.M. de Bont, Olga V. Aleinikova, Meinolf Suttorp
Journal: Blood (2014)
A Randomized, Open-Label, Multicenter, Dose Escalation Study of HQK-1001 (2,2-Dimethylbutyrate, Sodium Salt) in Sickle Cell Disease
Authors: Abdullah Kutlar, Marvin Reid, Ali T Taher, Adlette Inati, Miguel R. Abboud, Amal El-Beshlawy, George R. Buchanan, Hedy Smith, Kenneth I. Ataga, Nebu Koshy, Lynne D Neumayr, Punam Malik, Ofelia A. Alvarez, Richard Ward, J Michael White, Elsa Johnson, Richard G. Ghalie
Journal: Blood (2012)
Development of Quality Metrics in Ambulatory Pediatric Cardiology
Authors: Devyani Chowdhury, Michelle Gurvitz, Ariane Marelli, Jeffrey Anderson, Carissa Baker-Smith, Karim A. Diab, Thomas C. Edwards, Tom Hougen, Roy Jedeikin, Jonathan N. Johnson, Peter Karpawich, Wyman Lai, Jimmy C. Lu, Stephanie Mitchell, Jane W. Newburger, Daniel J. Penny, Michael A. Portman, Gary Satou, David Teitel, Juan Villafane, Roberta Williams, Kathy Jenkins, Roberta Williams, Kathy Jenkins, Michelle Gurvitz, Ariane Marelli, Robert Campbell, Devyani Chowdhury, Roy Jedeikin, Sarina Behera, John Hokanson, Jimmy Lu, Bahram Kakavand, Jeff Boris, Brian Cardis, Manish Bansal, Jeffrey Anderson, Amy Schultz, Matthew O'Connor, Jeffrey M. Vinocur, Nancy Halnon, Jonathan Johnson, Cindy Barrett, Eric Graham, Catherine Krawczeski, Wayne Franklin, James McGovern, Brandy Hattendorf, David Teitel, Timothy Cotts, Alex Davidson, Ashraf Harahsheh, Walter Johnson, Pei-Ni Jone, Nicole Sutton, Lloyd Tani, Nagib Dahdah, Michael Portman, Deborah Mensch, Jane Newburger, Thomas Hougen, Russell Cross, Karim Diab, Peter Karpawich, Wyman Lai, Matthias Peuster, Russell Schiff, Elizabeth Saarel, Gary Satou, Gerald Serwer, Juan Villafane, Tom Edwards, Daniel Penny, Karina Carlson, K. Anitha Jayakumar, Matthew Park, Nikola Tede, Karen Uzark, Carissa Baker Smith, Craig Fleishman, David Connuck, Jose Ettedgui, Maggie Likes, Takeshi Tsuda
Journal: Journal of the American College of Cardiology (2017)
Long-Term Prognostic Significance of Response in Hodgkin Lymphoma Before Autologous Stem Cell Transplantation :Results of the Prospective Multicenter H96 Trial by the GELA/SFGM-TC Study Group
Authors: David Sibon, Matthieu Resche-Rigon, Franck Morschhauser, Christophe Fermé, Isabelle Gaillard, Ambroise Marcais, Reda Bouabdallah, Catherine Sebban, Gilles Andre Salles, Pauline Brice
Journal: Blood (2011)
The human longevity gene homolog INDY and interleukin‐6 interact in hepatic lipid metabolism
Authors: Christian von Loeffelholz, Stefanie Lieske, Frank Neuschäfer‐Rube, Diana M. Willmes, Nathanael Raschzok, Igor M. Sauer, Jörg König, Martin F. Fromm, Paul Horn, Antonios Chatzigeorgiou, Andrea Pathe‐Neuschäfer‐Rube, Jens Jordan, Andreas F.H. Pfeiffer, Geltrude Mingrone, Stefan R. Bornstein, Peter Stroehle, Christoph Harms, F. Thomas Wunderlich, Stephen L. Helfand, Michel Bernier, Rafael de Cabo, Gerald I. Shulman, Triantafyllos Chavakis, Gerhard P. Püschel, Andreas L. Birkenfeld
Journal: Hepatology (2017)

Reduced expression of the Indy (“I am Not Dead, Yet”) gene in lower organisms promotes longevity in a manner akin to caloric restriction. Deletion of the mammalian homolog of Indy ( mIndy, Slc13a5 ) encoding for a plasma membrane–associated citrate transporter expressed highly in the liver, protects mice from high‐fat diet–induced and aging‐induced obesity and hepatic fat accumulation through a mechanism resembling caloric restriction. We studied a possible role of mIndy in human hepatic fat metabolism. In obese, insulin‐resistant patients with nonalcoholic fatty liver disease, hepatic mIndy expression was increased and mIndy expression was also independently associated with hepatic steatosis. In nonhuman primates, a 2‐year high‐fat, high‐sucrose diet increased hepatic mIndy expression. Liver microarray analysis showed that high mIndy expression was associated with pathways involved in hepatic lipid metabolism and immunological processes. Interleukin‐6 (IL‐6) was identified as a regulator of mIndy by binding to its cognate receptor. Studies in human primary hepatocytes confirmed that IL‐6 markedly induced mIndy transcription through the IL‐6 receptor and activation of the transcription factor signal transducer and activator of transcription 3, and a putative start site of the human mIndy promoter was determined. Activation of the IL‐6–signal transducer and activator of transcription 3 pathway stimulated mIndy expression, enhanced cytoplasmic citrate influx, and augmented hepatic lipogenesis in vivo . In contrast, deletion of mIndy completely prevented the stimulating effect of IL‐6 on citrate uptake and reduced hepatic lipogenesis. These data show that mIndy is increased in liver of obese humans and nonhuman primates with NALFD. Moreover, our data identify mIndy as a target gene of IL‐6 and determine novel functions of IL‐6 through mINDY. Conclusion : Targeting human mINDY may have therapeutic potential in obese patients with nonalcoholic fatty liver disease. German Clinical Trials Register: DRKS00005450. (H epatology 2017;66:616–630).
The Pro-Metastasis Tyrosine Phosphatase, PRL-3 (PTP4A3), Is a Novel Target of BCR-ABL Signaling Involved in Human Chronic Myeloid Leukemia
Authors: Jianbiao Zhou, Lip-Lee Cheong, Sylvia Mahara, Shaw-Cheng Liu, Phyllis SY Chong, Chonglei Bi, Tze-Loong Koh, Kelly OK Ong, Qi Zeng, Wee-Joo Chng
Journal: Blood (2011)
Permanent Alopecia in Children Following Busulfan Based Conditioning Is Associated with Glutathione M1 Null Genotype.
Authors: J. David Dennison, S. Muralitharan, Melanie Tauro, Shoaib Zadjali, Salam Al Kindi, Maria Lourdes Macalalad, Anil Pathare, Krishnaratnam Kannan, Aqueela Taqi Al Lawatia, R. Krishnamoorthy, Shyam Sunder Ganguly
Journal: Blood (2005)
Factor VIII Is a Potential Autosomal B Cell Minor Histocompatibility Antigen in Chronic Gvhd.
Authors: Stefanie Sarantopoulos, Corey Cutler, Grace Makari-Judson, Patricia Ropp, Whitney Washel, Vladimir Brusic, David DeLuca, Juan-Sebastian Saldivar, Robert J Soiffer, Joseph H. Antin, Jerome Ritz
Journal: Blood (2009)
Understanding Psychiatric Disorders in People With 22q11.2 Deletion and Duplication
Authors: James C. Harris
Journal: JAMA Psychiatry (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Psychiatry HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Psychiatry journal
Prevalence of Pelvic Inflammatory Disease in Sexually Experienced Women of Reproductive Age — United States, 2013–2014
Authors: Kristen Kreisel, Elizabeth Torrone, Kyle Bernstein, Jaeyoung Hong, Rachel Gorwitz
Journal: MMWR Morbidity and Mortality Weekly Report (2017)

Pelvic inflammatory disease (PID) is a clinical syndrome of the female reproductive tract characterized by inflammation of the endometrium, fallopian tubes, or peritoneum (1). PID occurs when microorganisms ascend from the vagina or cervix to the fallopian tubes and other upper genital tract structures (1). PID can result from untreated bacterial infections, including chlamydia and gonorrhea, and can lead to infertility, ectopic pregnancy, and chronic pelvic pain (1). Because there is no single diagnostic test for PID, clinicians rely on nonspecific signs and symptoms for diagnosis. The purpose of these analyses was to assess the burden of self-reported PID in a nationally representative sample using data from the National Health and Nutrition Examination Survey (NHANES) 2013-2014 cycle. Starting in 2013, NHANES female participants aged 18-44 years were asked about a lifetime history of PID diagnosis. Based on these data, the estimated prevalence of self-reported lifetime PID was 4.4% in sexually experienced women of reproductive age (18-44 years). The prevalence of self-reported lifetime PID was highest in women at increased risk, such as women reporting a previous sexually transmitted infection (STI) diagnosis. Stratified by race/ethnicity and having a previous STI diagnosis, non-Hispanic black (black) and non-Hispanic white (white) women reporting a previous STI diagnosis had nearly equal self-reported lifetime PID prevalence (10.0% versus 10.3%). However, the lifetime prevalence of PID among black women was 2.2 times that among white women if no previous STI was diagnosed (6.0% versus 2.7%). These findings suggest that PID is prevalent and associated with previous STI diagnoses; therefore, it is important for clinicians to screen female patients for chlamydia and gonorrhea to reduce the incidence of PID.
The Complex Transcriptional Landscape of the Human Platelet
Authors: Paul F. Bray, Steven E. McKenzie, Leonard C. Edelstein, Srikanth Nagalla, Kathleen Delgrosso, Adam Ertel, Joan Kupper, Yi Jing, Eric R. Londin, Phillipe Loher, Huang-Wen Chen, Paolo M. Fortina, Isidore Rigoutsos
Journal: Blood (2012)
Coping styles and psychological outcomes in men with advanced cancer
Authors: K. Schmidt, P. Monahan, Y. Tong, S. Rawl, K. Rand, L. D. Cripe
Journal: Journal of Clinical Oncology (2009)

e20521 Background: The psychological outcomes of men with advanced cancer may vary based upon their appraisal and response to the threat of cancer. Coping styles in other illnesses are influenced by gender and stage of disease, but little is known specifically about men with advanced cancer. Methods: We recruited 81 men with advanced cancer to complete surveys assessing coping (Mini-MAC), post-traumatic growth (PTGI), and psychological outcomes (Hospital Anxiety and Depression Scale). Psychological outcomes and coping styles were determined with means, and percentages above established cutoff points. Relationships were assessed using Pearson correlation coefficients. Results: The mean HADS anxiety and depression scores were 5.4 and 4.0, respectively. Fourteen men (17%) scored 8–10 and 8 (10%) scored ≥11 suggesting an anxiety state and disorder, respectively. Eight men (10%) had scores suggesting a depressive state and 4 (5%) a depressive disorder. Greater helplessness/hopelessness and anxious preoccupation scores were correlated with greater anxiety (r =.54, p&lt;.0001; r =.66, p&lt;.0001) and depression scores (r =.43, p&lt;.0001; r=.47, p&lt;.0001). Greater fighting spirit correlated with less anxiety (r =-.26, p=.018) and less depression (r = -.42, p &lt; .0001) and with increased post-traumatic growth in the form of new possibilities (r = .26, p = .020), personal strength (r = .33, p = .003), and the total PTGI score (r = .23, p = .043). Greater fatalism was associated with lower total distress measured by the total HADS score (r = -.24, p = .032), and marginally so when assessed separately for anxiety (r = -.22, p = .052) and depression (r = -.21, p = .056). In addition, greater fatalism was significantly associated with greater post-traumatic growth in all five areas assessed by the PTGI subscales (.27 &lt; r &lt; .36; .001 p &lt; .032). Conclusions: As expected men with advanced cancer report anxiety and depression. Coping styles were significantly associated with anxiety, depression, and post-traumatic growth. No significant financial relationships to disclose.
Clinical Efficacy of Mitoxantrone-Based Salvage Chemotherapy in Adult Patients with Relapsed or Refractory All; Retrospective Multicenter Study of Korean Adult ALL Working Party
Authors: Jae-Sook Ahn, Deok-Hwan Yang, Sung-Hoon Jung, Je-Jung Lee, Inho Kim, Seonyang Park, Joo-Seop Jung, Ho-Jin Shin, Dae-Young Kim, Kyoo-Hyung Lee, Joon Ho Moon, Sang Kyun Sohn, Ik-Chan Song, Deog Yeon Jo
Journal: Blood (2012)
Screening for Obstructive Sleep Apnea in Adults
Authors: Kirsten Bibbins-Domingo, David C. Grossman, Susan J. Curry, Karina W. Davidson, John W. Epling, Francisco A. R. García, Jessica Herzstein, Alex R. Kemper, Alex H. Krist, Ann E. Kurth, C. Seth Landefeld, Carol M. Mangione, William R. Phillips, Maureen G. Phipps, Michael P. Pignone, Michael Silverstein, Chien-Wen Tseng
Journal: JAMA (2017)

Based on data from the 1990s, estimated prevalence of obstructive sleep apnea (OSA) in the United States is 10% for mild OSA and 3.8% to 6.5% for moderate to severe OSA; current prevalence may be higher, given the increasing prevalence of obesity. Severe OSA is associated with increased all-cause mortality, cardiovascular disease and cerebrovascular events, diabetes, cognitive impairment, decreased quality of life, and motor vehicle crashes. To issue a new US Preventive Services Task Force (USPSTF) recommendation on screening for OSA in asymptomatic adults. The USPSTF reviewed the evidence on the accuracy, benefits, and potential harms of screening for OSA in asymptomatic adults seen in primary care, including those with unrecognized symptoms. The USPSTF also evaluated the evidence on the benefits and harms of treatment of OSA on intermediate and final health outcomes. The USPSTF found insufficient evidence on screening for or treatment of OSA in asymptomatic adults or adults with unrecognized symptoms. Therefore, the USPSTF was unable to determine the magnitude of the benefits or harms of screening for OSA or whether there is a net benefit or harm to screening. The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for OSA in asymptomatic adults. (I statement).
EORTC 18991 phase III trial: Long-term adjuvant pegylated interferon-α2b (PEG-IFN) versus observation in resected stage III melanoma: Long-term results at 7.6-years follow-up.
Authors: A. M. Eggermont, S. Suciu, M. Santinami, W. Kruit, A. Testori, J. Marsden, C. J. A. Punt, M. E. Gore, R. MacKie, R. Dummer, D. Schadendorf, P. Patel, A. Spatz, U. Keilholz
Journal: Journal of Clinical Oncology (2011)

8506b Background: EORTC 18991 is the largest adjuvant trial ever conducted in stage III melanoma. It assessed the efficacy and toxicity of long-term PEG-IFN vs Observation (Obs.). Methods: PEG-IFN (Induction at 6µg/Kg/wk, sc, 8 weeks; followed by Maintenance at 3µg/Kg/wk, sc) for a total treatment duration of up to 5 years was compared to Obs. in 1256 patients (pts) with stage III melanoma (anyTN1-2M0 without in-transit metastases). Randomization was stratified for nodal involvement N1 (microscopic) vs N2 (palpable nodes), # of nodes, Breslow and ulceration of primary, sex and center. Distant metastasis-free survival (DMFS) was the primary endpoint. Relapse-free survival (RFS) was the pre-specified regulatory primary endpoint. Overall survival (OS) was the secondary endpoint. Intent-to-treat analysis was performed Results: Median follow-up was 7.6 yrs is shown in the table. Conclusions: Long-term PEG-IFN therapy in stage III melanoma had a significant and sustained impact on RFS, but not on DMFS and OS. Pts with only microscopic nodal involvement (sentinel node positive) seemed to have a greater benefit of PEG-IFN in terms of RFS, and marginally regarding DMFS and OS. In the smaller subgroup of pts with sentinel node positive and with ulcerated melanoma, the benefit seemed to be the most striking and consistent regarding all endpoints, and was maintained at long term follow-up. These effects have been observed in 2 consecutive EORTC trials (18952 and 18991) involving 2,644 pts. RFS DMFS OS All pts (N=1,256) Obs. PEG-IFN Obs. PEG-IFN Obs. PEG-IFN Nb. events 406 384 375 370 336 332 7-year rates 35% 39% 40% 42% 46% 48% Median (yrs) 2.2 3.0 3.2 3.9 5.6 6.2 HR (95%CI) 0.87 (0.76-1.00) 0.93 (0.81-1.07) 0.96 (0.82-1.11) P value 0.05 0.33 0.57 N2 pts (N=713) HR (99%CI) 0.89 (0.71-1.13) 0.96 (0.76-1.22) 1.00 (0.78-1.29) P value 0.21 0.66 0.97 N1 pts (N=543) HR (99%CI) 0.82 (0.61-1.10) 0.86 (0.63-1.17) 0.86 (0.62-1.21) P value 0.08 0.22 0.26 N1 pts & ulc. (N=186) HR (99%CI) 0.72 (0.46-1.13) 0.65 (0.41-1.04) 0.59 (0.35-0.97) p-value 0.06 0.02 0.006 Abbreviations: HR, hazard ratio; CI, confidence interval; N1, microscopic (sentinel node positive); N2, palpable nodes; ulc., ulcerated melanoma.
Development and Immunologic Characterization of Multi-Antigen Expressing Attenuated Poxviruses for Immunotherapy of CMV Infection in HSCT Recipients.
Authors: Don J. Diamond, Zhongde Wang, Corinna La Rosa, Goetz U. Grigoleit, Angelo Mandarino, Simon F. Lacey, Holger Ludwig, William J. Britt, Gerd Sutter, Hermann Einsele
Journal: Blood (2005)
Comparative Cellular Studies of the VWF Exon 4–5 Deletion Mutation Using Patient-Derived Blood Outgrowth Endothelial Cells (BOEC) and Megakaryocytes
Authors: Mackenzie L Bowman, Ling Li, Fred Pluthero, Hilary Christensen, Irwin Walker, Walter H. Kahr, Paula D. James
Journal: Blood (2012)
Chromosomal Abnormalities In Philadelphia Chromosome (Ph)-Negative Metaphases Appearing During Second Generation Tyrosine Kinase Inhibitors (2nd TKI) Therapy In Patients (pts) with Chronic Myeloid Leukemia (CML).
Authors: Elias Jabbour, Hagop Kantarjian, A. Megan Cornelison, Tapan Kadia, Mary-Alma Welch, Lynne V. Abruzzo, Jan A. Burger, Alessandra Ferrajoli, Guillermo Garcia-Manero, Jorge E. Cortes
Journal: Blood (2010)
Inhibition of Usp9x Deubiquitinase Activity by WP1130 Reduces Mcl-1 Levels and Induces Apoptosis In Cells From Patients with Plasma Cell Dyscrasia and Drug-Refractory Multiple Myeloma
Authors: Hanshi Sun, Vaibhav Kapuria, Luke F. Peterson, Diane Giannola, Kandarpa Malathi, Moshe Talpaz, Andrzej J Jakubowiak, Nicholas Donato
Journal: Blood (2010)
Female Smokers Are at Greater Risk of Airflow Obstruction Than Male Smokers. UK Biobank
Authors: André F. S. Amaral, David P. Strachan, Peter G. J. Burney, Deborah L. Jarvis
Journal: American Journal of Respiratory and Critical Care Medicine (2017)

Rationale: The prevalence of chronic obstructive pulmonary disease (COPD) is increasing faster among women than among men.Objectives: To examine sex differences in the risk of airflow obstruction (a COPD hallmark) in relation to smoking history.Methods: We analyzed 149,075 women and 100,252 men taking part in the UK Biobank who had provided spirometry measurements and information on smoking. The association of airflow obstruction with smoking characteristics was assessed by sex using regression analysis. The shape of this relationship was examined using restricted cubic splines.Measurements and Main Results: The association of airflow obstruction with smoking status was stronger in women (odds ratio for ex-smokers [ORex], 1.44; ORcurrent, 3.45) than in men (ORex, 1.25; ORcurrent, 3.06) (P for interaction = 5.6 × 10−4). In both sexes, the association of airflow obstruction with cigarettes per day, smoking duration, and pack-years did not follow a linear pattern, with the increase in risk at lower doses being steeper among women. For equal doses of exposure, sex differences were present in both ex-smokers and current smokers for cigarettes per day (P for interactionex = 6.0 × 10−8; P for interactioncurrent = 1.1 × 10−5), smoking duration (P for interactionex = 7.9 × 10−4; P for interactioncurrent = 0.004), and pack-years (P for interactionex = 6.6 × 10−18; P for interactioncurrent = 1.3 × 10−6). Overall, those who started smoking before age 18 years were more likely to have airflow obstruction, but a sex difference in this association was not clear. For equal time since quitting, the reduction in risk among women seemed less marked than among men.Conclusions: Exposed to the same dose of smoking, women showed a higher risk of airflow obstruction than men. This could partly explain the increasingly smaller sex difference in the prevalence of COPD, especially in countries where smoking patterns have become similar between women and men.
Efficacy and Clinical Outcome of Philadelphia (Ph) Positive Acute Lymphoblastic Leukemia (ALL) Patients Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs): The Bologna Experience.
Authors: Cristina Papayannidis, Ilaria Iacobucci, Simona Soverini, Sabrina Colarossi, Alessandra Gnani, Annalisa Lonetti, Carmen Baldazzi, Nicoletta Testoni, Marilina Amabile, Emanuela Ottaviani, Maria Chiara Abbenante, Antonio Curti, Stefania Paolini, Barbara Lama, Fausto Castagnetti, Angela Poerio, Cristina Clissa, Sarah Parisi, Nicola Polverelli, Viviana Guadagnuolo, Pier Paolo Piccaluga, Gianantonio Rosti, Michele Baccarani, Giovanni Martinelli
Journal: Blood (2009)
Proangiogenic Effects of Plasma From Sickle Cell Disease Patients and Antiangiogenic Effects of Hydroxyurea: Evaluation of Invasion and Proliferation of Human Endothelial Cells and Effects of Hydroxyurea in a Mouse Matrigel Plug Neovascularization Assay
Authors: Fláavia Cristine Mascia Lopes, Raquel Costa, Sara T Olalla Saad, Raquel Soares, Fernando Ferreira Costa, Nicola Conran
Journal: Blood (2012)
First Case of Platelet-Type Von Willebrand Disease (PT-VWD) Associated with Type 2B Von Willebrand Disease (2B VWD)
Authors: Marie Dreyfus, Celine Desconclois, Corinne Guitton, Marie-Jeanne Baas, Helene Mandard, Pierre Boisseau, Jenny Goudemand, Claudine Caron, Nathalie Itzhar, Agnes Veyradier, Francois Lanza, Edith Fressinaud
Journal: Blood (2011)
The Effect of Transfusion Dependency and Secondary Iron Overload on Survival of Patients with Myelodysplastic Syndrome.
Authors: Luca Malcovati, Matteo G. Della Porta, Cristiana Pascutto, Rosangela Invernizzi, Francesco Passamonti, Luca Arcaini, Margherita Maffioli, Elisa Rumi, Erica Travaglino, Paolo Bernasconi, Mario Lazzarino, Mario Cazzola
Journal: Blood (2005)
A Greater Mutational Complexity May Contribute to the Differential Prognostic Impact of Type 1/Type 1-like Versus Type 2/Type2-like Calreticulin Mutations in Primary Myelofibrosis
Authors: Paola Guglielmelli, Giada Rotunno, Tiziana Fanelli, Annalisa Pacilli, Laura Calabresi, Alessandro Pancrazzi, Alessandro M. Vannucchi
Journal: Blood (2015)